Patents/Assignees

Acerta Pharma B.V.

8 patents in portfolio

US12616682utility2026
1-h-pyrrolo[2,3-c]pyridine Compounds
0 cites
US12448387utility2025
Processes for the Preparation of 4-{8-amino-3-[(2s)-1-(but-2-ynoyl)-pyrrolidin-2-yljimidazo[1,5-a]-pyrazin-1-yl}n-(pyridin-2-yl)-benzamide
0 cites
US12263164utility2025
Methods of Treating Chronic Lymphocytic Leukemia and Small Lymphocytic Leukemia Using a BTK Inhibitor
0 cites
US12024520utility2024
Processes for the Preparation of 4-{8-amino-3-[(2s)-1-(but-2-ynoyl)-pyrrolidin-2-yl]imidazo[1,5-a]-pyrazin-1-yl}n-(pyridin-2-yl)-benzamide
0 cites
US11820777utility2023
Crystal Forms of (s)-4-(8-amino-3-(1-(but-2-ynoyl)pyrrolidin-2-yl)imidazo[1,5-a]pyrazin-1-yl)-n-(pyridin-2-yl)benzamide
0 cites
US11771696utility2023
Methods of Treating Chronic Lymphocytic Leukemia and Small Lymphocytic Leukemia Using a BTK Inhibitor
0 cites
US11654143utility2023
Therapeutic Combinations of a BTK Inhibitor, a PI3K Inhibitor, a JAK-2 Inhibitor, And/or a BCL-2 Inhibitor
0 cites
US11590167utility2023
Methods and Compositions for Use of Therapeutic T Cells in Combination with Kinase Inhibitors
0 cites